Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?


Drug Profile


Alternative Names: cis-Capsaicin; Civamide; Civamide 0.075% cream - Winston Pharmaceuticals; Civanex; Civanex Nasal Solution; Dolorac Nasal Solution; Neuroderm Patch; Zuacta

Latest Information Update: 17 Jul 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Winston Laboratories
  • Developer Sanofi; Winston Laboratories; Winston Pharmaceuticals
  • Class Catechols; Monounsaturated fatty acids; Polyunsaturated alkamides; Solanaceous alkaloids
  • Mechanism of Action TRPV1 receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Postherpetic neuralgia
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Pain
  • Phase II Keratoconjunctivitis sicca
  • No development reported Cluster headache; Crohn's disease; Migraine; Postherpetic neuralgia; Rhinitis

Most Recent Events

  • 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
  • 09 Jun 2015 No recent reports on development identified - Phase-II for Crohn's disease in USA (PO, capsule)
  • 09 Jun 2015 No recent reports on development identified - Phase-III for Cluster headache in USA (Intranasal, spray)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top